Inflammatory neuropathies of the enteric nervous system

Gastroenterology

Volumn 126, Issue 7, 2004, Pages 1872-1883

  De Giorgio, Roberto ^a,e   Guerrini, Stefania ^a   Barbara, Giovanni ^a   Stanghellini, Vincenzo ^a   De Ponti, Fabrizio ^a   Corinaldesi, Roberto ^a   Moses, Peter L ^b   Sharkey, Keith A ^c   Mawe, Gary M ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BECLOMETASONE; CELL ANTIBODY; CELL ANTIGEN; CYCLOPHOSPHAMIDE; HU PROTEIN; IMMUNOSUPPRESSIVE AGENT; ION CHANNEL; METHYLPREDNISOLONE; NEURONAL ANTIBODY; NEUROTRANSMITTER RECEPTOR; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG; YO PROTEIN;

ANTIBODY DETECTION; ANTIGEN EXPRESSION; AUTOIMMUNITY; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL FEATURE; ENTERIC GANGLIONITIS; ENTERITIS; ESOPHAGUS ACHALASIA; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATORY CELL; INTESTINE INNERVATION; INTESTINE PSEUDOOBSTRUCTION; IRRITABLE COLON; MEGACOLON; MOLECULAR MIMICRY; NERVE CELL; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROPATHY; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SHORT COURSE THERAPY; STOMACH PARESIS;

EID: 2942588975     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.02.024     Document Type: Article

References (94)

1. Bayliss WM, Starling EH. The movements and innervation of the small intestine. J Physiol 1899;24:99-143.
2. Bayliss WM, Starling EH. The movements and innervation of the small intestine. J Physiol 1900;26:125-138.
3. Bayliss WM, Starling EH. The movements and innervation of the large intestine. J Physiol 1900;26:107-118.
4. Trendelenburg P. Physiologische und pharmakologische Versuche über die Dunndarmperistaltik, Arch Exp Pathol Pharmakol 1917;81:55-129.
5. Gershon MD, Kirchgessner AL, Wade PR. Functional anatomy of the enteric nervous system. In: Johnson LR, ed. Physiology of the gastrointestinal tract. New York: Raven, 1994:381-422.
6. Furness JB, Costa M. The enteric nervous system. Edinburgh: Churchill Livingstone, 1987.
7. Furness JB, Bornstein JC. The enteric nervous system and its extrinsic connections. In: Yamada T, ed. Textbook of gastroenterology. New York: Lippincott, 1991:2-24.
8. Wood JD. Neural and humoral regulation of gastrointestinal motility. In: Schuster MM, Crowell MD, Koch KL, eds. Gastrointestinal motility in health and disease. London: BC Decker, 2002:19-42.
9. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995;346:861-864.
10. Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol (Berl) 1990;79:581-583.
11. Chen JJ, Gershon AA, Li ZS, Lungu O, Gershon MD. Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol 2003;70(suppl 1):S71-S78.
12. Horoupian DS, Kim Y. Encephalomyeloneuropathy with ganglionitis of the myenteric plexuses in the absence of cancer. Ann Neurol 1982;11:628-632.
13. Chinn JS, Schuffler MD. Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 1988;95:1279-1286.
14. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol 2001;96:373-379.
15. Sutton I, Winer J, Rowlands D, Dalmau J. Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer. J Neurol Neurosurg Psychiatry 2000;69:266-268.
16. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Shoenfeld Y, eds. Textbook of autoantibodies. Amsterdam: Elsevier Science, 1996:139-147.
17. Meneghelli UG. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 1985;18: 255-264.
18. Andersson J, Orn A, Sunnemark D. Chronic murine Chagas' disease: the impact of host and parasite genotypes. Immunol Lett 2003;86:207-212.
19. Caliari ER, Caliari MV, de Lana M, Tafuri WL. Quantitative and qualitative studies of the Auerbach and Meissner plexuses of the esophagus in dogs inoculated with Trypanosoma cruzi. Rev Soc Bras Med Trop 1996;29:17-20.
20. DeSchryver-Kecskemeti K, Clouse RE. Perineural and intraneural inflammatory infiltrates in the intestines of patients with systemic connective-tissue disease. Arch Pathol Lab Med 1989;113:394-398.
21. Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil 1998;10:189-202.
22. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648-654.
23. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol 1994;18:327-337.
24. Smith B. The neurological lesion in achalasia of the cardia. Gut 1970;11:388-391.
25. De Giorgio R, Barbara G, Stanghellini V, Cogliandro RF, Arrigoni A, Santini D, Ceccarelli C, Salvioli B, Rossini FP, Corinaldesi R. Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult. Eur J Gastroenterol Hepatol 2000;12:613-616.
26. Camilleri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord 2002;2:47-56.
27. Stanghellini V, Corinaldesi R, Barbara L. Pseudo-obstruction syndromes. Baillieres Clin Gastroenterol 1988;2:225-254.
28. Tornblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-1979.
29. Csendes A, Smok G, Braghetto I, Gonzalez P, Henriquez A, Csendes P, Pizurno D. Histological studies of Auerbach's plexuses of the oesophagus, stomach, jejunum, and colon in patients with achalasia of the oesophagus: correlation with gastric acid secretion, presence of parietal cells and gastric emptying of solids. Gut 1992;33:150-154.
30. Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, Malagelada JR. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993;23:724-728.
31. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986;90:924-929.
32. Richter JE. Oesophageal motility disorders. Lancet 2001;358: 823-828.
33. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996;334:1106-1115.
34. Krishnamurthy S, Schuffier MD. Pathology of neuromuscular disorders of the small intestine and colon. Gastroenterology 1987; 93:610-639.
35. Lukens FJ, Machicao VI, Woodward TA, DeVault KR. Esophageal sarcoidosis: an unusual diagnosis. J Clin Gastroenterol 2002; 34:54-56.
36. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Clin Neurosci 1998;5:136-146.
37. McDonald GB, Schuffler MD, Kadin ME, Tytgat GN. Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine. Gastroenterology 1985;89:882-889.
38. Ruuska TH, Karikoski R, Smith VV, Milla PJ. Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis. Gastroenterology 2002;122:1133-1139.
39. Krishnamurthy S, Schuffler MD, Belic L, Schweid Al. An inflammatory axonopathy of the myenteric plexus producing a rapidly progressive intestinal pseudoobstruction. Gastroenterology 1986;90:754-758.
40. De Giorgio R, Barbara G, Stanghellini V, De Ponti F, Salvioli B, Tonini M, Velio P, Bassotti G, Corinaldesi R. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol 2002;97:2454-2459.
41. Smith VV, Gregson N, Foggensteiner L, Neale G, Milla PJ. Acquired intestinal aganglionosis and circulating autoantibodies without neoplasia or other neural involvement. Gastroenterology 1997;112:1366-1371.
42. De Giorgio R, Stanghellini V, Barbara G, Corinaldesi R, De Ponti F, Tonini M, Bassotti G, Sternini C. Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000;35:114-122.
43. Schappi MG, Smith VV, Milla PJ, Lindley KJ. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 2003;52:752-755.
44. Wood JD. Neuropathy in the brain-in-the-gut. Eur J Gastroenterol Hepatol 2000;12:597-600.
45. Schobinger-Clement S, Gerber HA, Stallmach T. Autoaggressive inflammation of the myenteric plexus resulting in intestinal pseudoobstruction. Am J Surg Pathol 1999;23:602-606.
46. Di Lorenzo C. Pseudo-obstruction: current approaches. Gastroenterology 1999;116:980-987.
47. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut 1987;28:5-12.
48. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999; 45(suppl 2):1137-1142.
49. Hiatt RB, Katz L. Mast cells in inflammatory conditions of the gastrointestinal tract. Am J Gastroenterol 1962;37:541-545.
50. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51(suppl 1):i41-i44.
51. Barbara G, Stanghellini V, DeGiorgio R, Cremon C, Cottrel GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
52. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44:400-406.
53. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-811.
54. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-1671.
55. Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000;24:1153-1158.
56. De Giorgio R, Barbara G, Pulsatelli L, Stanghellini V, Dolzani P, Meliconi R, Mazzotta E, Benedikter M, Corradi F, Facchini A, Collins SM, Corinaldesi R. Chemokine expression and lymphocyte subsets in patients with idiopathic myenteric ganglionitis (abstr). Gastroenterology 2000;118:A630.
57. Kalff JC, Carlos TM, Schraut WH, Billiar TR, Simmons RL, Bauer AJ. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999;117:378-387.
58. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:565-568.
59. Moses PL, Ellis LM, Anees MR, Ho W, Rothstein RI, Meddings JB, Sharkey KA, Mawe GM. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003;52: 629-636.
60. Ruhl A, Trotter J, Stremmel W. Isolation of enteric glia and establishment of transformed enteroglial cell lines from the myenteric plexus of adult rat. Neurogastroenterol Motil 2001;13: 95-106.
61. Ruhl A, Franzke S, Collins SM, Stremmel W. Interleukin-6 expression and regulation in rat enteric glial cells. Am J Physiol Gastrointest Liver Physiol 2001;280:G1163-G1171.
62. Bush TG, Savidge TC, Freeman TC, Cox HJ, Campbell EA, Mucke L, Johnson MH, Sofroniew MV. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 1998;93: 189-201.
63. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999;23:297-308.
64. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology 1991;100:137-142.
65. King PH, Redden D, Palmgren JS, Nabors LB, Lennon VA. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease. J Autoimmun 1999;13:435-443.
66. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999;53:1233-1239.
67. Pande R, Leis AA. Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody. Muscle Nerve 1999;22:1600-1602.
68. Gerl A, Storck M, Schalhorn A, Muller-Hocker J, Jauch KW, Schildberg FW, Wilmanns W. Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid. Gut 1992;33:1000-1003.
69. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554.
70. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002;20:85-122.
71. Voltz RD, Posner JB, Dalmau J, Graus F. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour. J Neurol Neurosurg Psychiatry 1997;63:133-136.
72. Benyahia B, Liblau R, Merle-Beral H, Tourani JM, Dalmau J, Delattre JY. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol 1999; 45:162-167.
73. Sutton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond) 2002;102:475-486.
74. Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 1997;17:3024-3037.
75. Wakamatsu Y, Weston JA. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 1997; 124:3449-3460.
76. Lin Z, Gao N, Hu HZ, Liu S, Gao C, Kim G, Ren J, Xia Y, Peck OC, Wood JD. Immunoreactivity of Hu proteins facilitates identification of myenteric neurones in guinea-pig small intestine. Neurogastroenterol Motil 2002;14:197-204.
77. De Giorgio R, Bovara M, Barbara G, Canossa M, Sarnelli G, De Ponti F, Stanghellini V, Tonini M, Cappello S, Pagnotta E, Nobile-Orazio E, Corinaldesi R. Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology 2003;125:70-79.
78. Carpentier AF, Delattre JY. The Lambert-Eaton myasthenic syndrome, Clin Rev Allergy Immunol 2001;20:155-158.
79. Waterman SA. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 2001;11:145-154.
80. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-855.
81. Okano HJ, Park WY, Corradi JP, Darnell RB. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev 1999;13:2087-2097.
82. Williams-Blangero S, VandeBerg JL, Blangero J, Correa-Oliveira R. Genetic epidemiology of Trypanosoma cruzi infection and Chagas' disease. Front Biosci 2003;8:E337-E345.
83. Chamond N, Coatnoan N, Minoprio P. Immunotherapy of Trypanosoma cruzi infections. Curr Drug Targets Immune Endocr Metabol Disord 2002;2:247-254.
84. Van Voorhis WC, Schlekewy L, Trong HL. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci U S A 1991;88:5993-5997.
85. Goin JC, Sterin-Borda L, Bilder CR, Varrica LM, Iantorno G, Rios MC, Borda E. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. Gastroenterology 1999;117:798-805.
86. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology 1991;100:252-258.
87. Chang AE, Young NA, Reddick RL, Orenstein JM, Hosea SW, Katz P, Brennan MF. Small bowel obstruction as a complication of disseminated varicella-zoster infection. Surgery 1978;83:371-374.
88. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993;34: 299-302.
89. Debinski HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut 1997;41:100-106.
90. Sonsino E, Mouy R, Foucaud P, Cezard JP, Aigrain Y, Bocquet L, Navarro J. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus. N Engl J Med 1984;311:196-197.
91. Bogers J, Moreels T, De Man J, Vrolix G, Jacobs W, Pelckmans P, van Marck E. Schistosoma mansoni infection causing diffuse enteric inflammation and damage of the enteric nervous system in the mouse small intestine. Neurogastroenterol Motil 2000;12: 431-440.
92. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med 1999;50:37-55.
93. Camilleri M. Abnormalities of enteric and extrinsic nervous system and motility disorders. In: Krammer HJ, Singer MV, eds. Neurogastroenterology: from the basics to the clinics. Falk Symposium 112. Dordrecht: Kluwer Academic, 1999:424-440.
94. Tack J, Demedts I, Dehondt G, Caenepeel P, Fischler B, Zandecki M, Janssens J. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002;122: 1738-1747.